BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 15710815)

  • 1. Pointwise linear regression for evaluation of visual field outcomes and comparison with the advanced glaucoma intervention study methods.
    Nouri-Mahdavi K; Caprioli J; Coleman AL; Hoffman D; Gaasterland D
    Arch Ophthalmol; 2005 Feb; 123(2):193-9. PubMed ID: 15710815
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predictive factors for glaucomatous visual field progression in the Advanced Glaucoma Intervention Study.
    Nouri-Mahdavi K; Hoffman D; Coleman AL; Liu G; Li G; Gaasterland D; Caprioli J;
    Ophthalmology; 2004 Sep; 111(9):1627-35. PubMed ID: 15350314
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A comparison of visual field progression criteria of 3 major glaucoma trials in early manifest glaucoma trial patients.
    Heijl A; Bengtsson B; Chauhan BC; Lieberman MF; Cunliffe I; Hyman L; Leske MC
    Ophthalmology; 2008 Sep; 115(9):1557-65. PubMed ID: 18378317
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of methods to predict visual field progression in glaucoma.
    Nouri-Mahdavi K; Hoffman D; Ralli M; Caprioli J
    Arch Ophthalmol; 2007 Sep; 125(9):1176-81. PubMed ID: 17846355
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pointwise linear regression analysis for detection of visual field progression with absolute versus corrected threshold sensitivities.
    Manassakorn A; Nouri-Mahdavi K; Koucheki B; Law SK; Caprioli J
    Invest Ophthalmol Vis Sci; 2006 Jul; 47(7):2896-903. PubMed ID: 16799031
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Advanced Glaucoma Intervention Study (AGIS): 14. Distinguishing progression of glaucoma from visual field fluctuations.
    Kim J; Dally LG; Ederer F; Gaasterland DE; VanVeldhuisen PC; Blackwell B; Sullivan EK; Prum B; Shafranov G; Beck A; Spaeth GL;
    Ophthalmology; 2004 Nov; 111(11):2109-16. PubMed ID: 15522379
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pointwise Methods to Measure Long-term Visual Field Progression in Glaucoma.
    Salazar D; Morales E; Rabiolo A; Capistrano V; Lin M; Afifi AA; Yu F; Nouri-Mahdavi K; Caprioli J
    JAMA Ophthalmol; 2020 May; 138(5):536-543. PubMed ID: 32239185
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intraocular pressure fluctuation a risk factor for visual field progression at low intraocular pressures in the advanced glaucoma intervention study.
    Caprioli J; Coleman AL
    Ophthalmology; 2008 Jul; 115(7):1123-1129.e3. PubMed ID: 18082889
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of visual field testing frequency on detection of glaucoma progression with trend analyses.
    Nouri-Mahdavi K; Zarei R; Caprioli J
    Arch Ophthalmol; 2011 Dec; 129(12):1521-7. PubMed ID: 21825177
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical comparison of pascal dynamic contour tonometry and goldmann applanation tonometry in asymmetric open-angle glaucoma.
    Sullivan-Mee M; Halverson KD; Qualls C
    J Glaucoma; 2007 Dec; 16(8):694-9. PubMed ID: 18091457
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Scoring systems for measuring progression of visual field loss in clinical trials of glaucoma treatment.
    Katz J
    Ophthalmology; 1999 Feb; 106(2):391-5. PubMed ID: 9951496
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Optic disc progression and rates of visual field change in treated glaucoma.
    De Moraes CG; Liebmann JM; Park SC; Teng CC; Nemiroff J; Tello C; Ritch R
    Acta Ophthalmol; 2013 Mar; 91(2):e86-91. PubMed ID: 23356423
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of focal lamina cribrosa defect on glaucomatous visual field progression.
    Faridi OS; Park SC; Kabadi R; Su D; De Moraes CG; Liebmann JM; Ritch R
    Ophthalmology; 2014 Aug; 121(8):1524-30. PubMed ID: 24697910
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The region of largest β-zone parapapillary atrophy area predicts the location of most rapid visual field progression.
    Teng CC; De Moraes CG; Prata TS; Liebmann CA; Tello C; Ritch R; Liebmann JM
    Ophthalmology; 2011 Dec; 118(12):2409-13. PubMed ID: 21885127
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Optic disc and visual field changes after trabeculectomy.
    Kotecha A; Spratt A; Bunce C; Garway-Heath DF; Khaw PT; Viswanathan A;
    Invest Ophthalmol Vis Sci; 2009 Oct; 50(10):4693-9. PubMed ID: 19474409
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Monitoring glaucomatous progression using a novel Heidelberg Retina Tomograph event analysis.
    Fayers T; Strouthidis NG; Garway-Heath DF
    Ophthalmology; 2007 Nov; 114(11):1973-80. PubMed ID: 17662455
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Statistical evaluation of the diagnostic accuracy of methods used to determine the progression of visual field defects in glaucoma.
    Mayama C; Araie M; Suzuki Y; Ishida K; Yamamoto T; Kitazawa Y; Shirakashi M; Abe H; Tsukamoto H; Mishima HK; Yoshimura K; Ohashi Y
    Ophthalmology; 2004 Nov; 111(11):2117-25. PubMed ID: 15522380
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interocular asymmetry of visual field defects in primary open angle glaucoma and primary angle-closure glaucoma.
    Wang JC; Gazzard G; Foster PJ; Devereux JG; Oen FT; Chew PT; Khaw PT; Seah SK
    Eye (Lond); 2004 Apr; 18(4):365-8. PubMed ID: 15069431
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Usefulness of frequency-doubling technology for perimetrically normal eyes of open-angle glaucoma patients with unilateral field loss.
    Fan X; Wu LL; Ma ZZ; Xiao GG; Liu F
    Ophthalmology; 2010 Aug; 117(8):1530-7, 1537.e1-2. PubMed ID: 20466428
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Global and pointwise rates of decay in glaucoma eyes deteriorating according to pointwise event analysis.
    Nassiri N; Moghimi S; Coleman AL; Law SK; Caprioli J; Nouri-Mahdavi K
    Invest Ophthalmol Vis Sci; 2013 Feb; 54(2):1208-13. PubMed ID: 23329667
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.